Experiment 67087

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationPEPE,C: ROZZA,A: VERONESI,G:. (1999). VIDEO CAPILLAROSCOPY EVALUATION OF EFFICACY GINKGO BILOBA EXTRACT WITH L-ARGININE AND MAGNESIUM IN THE TREATMENT OF TROPHIC LESIONS IN PATIENTS WITH STAGE 4 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE.. 47(6)
Amount utilized
Compound isolated
DiseaseSTUDY AIMED TO EVALUATE THE INFLUENCE OF GINKGO-BILOBA EXTRACT WITH ARGININE AND MAGNESIUM USED FOR THE TREATMENT OF TROPHIC LESIONS IN THE LOWER LIMBS CAUSED BY BOTH DIABETIC AND NON-DIABETIC MICROANGIOPATHY. A COMPARATIVE STUDY WAS CARRIED OUT IN 20 PATIENTS WHO WERE DIVIDED INTO TWO GROUPS:10 WERE TREATED WITH ASA PLUS GINKGO BILOBA EXTRACT WITH ARGININE AND MAGNESIUM AND 10 WITH ASA PLUS CONVENTIONAL HEMORRHEOLOGY. THE OBSERVATION TIME WAS EXTENDED TO 6 MONTHS, TAKING INTO CONSIDERATION PATIENTS WITH TROPHIC LESIONS TO THE LOWER LIMBS SUFFERING FROM DIABETIC AND NON-DIABETIC PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. THE EVALUATION WAS PERFORMED BY CLINICAL, ULTRASONOGRAPHIC AND PERILESIONAL VIDEO CAPILLAROSCOPY MONITORING. ULTRASONOGRAPHIC AND VIDEO CAPILLAROSCOPY INSTRUMENTAL METHODS WERE USED BECAUSE THEY PROVIDE A FULL PICTURE OF MACRO AND MICROCIRCULATORY CONDITIONS AROUND LESIONS. THE STUDY SHOWED THE UNDOUBTED EFFICACY OF GINKGO-BILOBA EXTRACT WITH MAGNESIUM AND ARGINENE IN RELATION TO THE FOLLOWING POINT:REDUCED HEALING TIMES FOR THE TROPHIC LESION COMPARED TO THE CONTROL GROUP, IMPROVED PAINFUL SUMPTOMS, INCREASED PERILESIONAL NEOANGIOGENESIS.
Dose amount240.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderGIVEN TO BOTH SEXES